Search research articles
Contact Us
Filters
Showing results (31-40 of 259) with videos related to
Page
of 26
Sort By:
Advances in Nephrology From the Necker Hospital
|
January 1, 1985
Immunologic problems and perspectives in the therapeutic use of monoclonal antibodies in nephrology
J F Bach, L Chatenoud
Seminars in Immunology
|
November 1, 1990
Monoclonal antibodies to CD3 as immunosuppressants
L Chatenoud, J F Bach
Seminars in Nephrology
|
May 1, 1996
T cells and B cells in chronic renal failure
B Descamps-Latscha, L Chatenoud
Annales D'Immunologie
|
September 1, 1982
The significance of T-cell subsets defined by monoclonal antibodies in human diseases
J F Bach, L Chatenoud
Immunology Today
|
October 8, 2014
Antigenic modulation - a major mechanism of antibody action
L Chatenoud, J F Bach
Annual Review of Immunology
|
March 13, 2001
Tolerance to islet autoantigens in type 1 diabetes
J F Bach, L Chatenoud
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1991
[T lymphocyte activation induced by monoclonal anti-CD3 antibodies: physiopathology of cytokine release]
L Chatenoud, J F Bach
Immunology Series
|
January 1, 1993
T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies
L Chatenoud, J F Bach
Immunology Today
|
March 1, 1995
Tolerance induction in the adult: 'danger' at Le Bischenberg
L Chatenoud, H Waldmann, F Emmrich
Advances in Nephrology From the Necker Hospital
|
January 1, 1991
Clinical applications of anti-T-cell monoclonal antibodies
L Chatenoud, C Ferran, J F Bach
Page
of 26
Search research articles
Search
Showing results (31-40 of 259) with videos related to
Sort By:
Page
of 26
Advances in Nephrology From the Necker Hospital
|
January 1, 1985
Immunologic problems and perspectives in the therapeutic use of monoclonal antibodies in nephrology
J F Bach, L Chatenoud
Seminars in Immunology
|
November 1, 1990
Monoclonal antibodies to CD3 as immunosuppressants
L Chatenoud, J F Bach
Seminars in Nephrology
|
May 1, 1996
T cells and B cells in chronic renal failure
B Descamps-Latscha, L Chatenoud
Annales D'Immunologie
|
September 1, 1982
The significance of T-cell subsets defined by monoclonal antibodies in human diseases
J F Bach, L Chatenoud
Immunology Today
|
October 8, 2014
Antigenic modulation - a major mechanism of antibody action
L Chatenoud, J F Bach
Annual Review of Immunology
|
March 13, 2001
Tolerance to islet autoantigens in type 1 diabetes
J F Bach, L Chatenoud
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|
January 1, 1991
[T lymphocyte activation induced by monoclonal anti-CD3 antibodies: physiopathology of cytokine release]
L Chatenoud, J F Bach
Immunology Series
|
January 1, 1993
T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies
L Chatenoud, J F Bach
Immunology Today
|
March 1, 1995
Tolerance induction in the adult: 'danger' at Le Bischenberg
L Chatenoud, H Waldmann, F Emmrich
Advances in Nephrology From the Necker Hospital
|
January 1, 1991
Clinical applications of anti-T-cell monoclonal antibodies
L Chatenoud, C Ferran, J F Bach
Page
of 26